These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 10099914)
1. Pharmacological treatment for hyperlipidaemia--the best preventive measure? Rosengren A; Swedberg K Eur Heart J; 1999 Feb; 20(4):245-6. PubMed ID: 10099914 [No Abstract] [Full Text] [Related]
2. Management of hyperlipidaemia: postscript. Sum CF; Tan CE; Chew LS Singapore Med J; 1995 Oct; 36(5):538. PubMed ID: 8882543 [No Abstract] [Full Text] [Related]
4. Lipids and their role in coronary heart disease: what they do and how to manage them. Pradka LR Nurs Clin North Am; 2000 Dec; 35(4):981-91. PubMed ID: 11072283 [TBL] [Abstract][Full Text] [Related]
6. Aggressive medical therapy for the prevention and treatment of coronary artery disease. Malloy MJ; Kane JP Adv Intern Med; 1997; 42():1-38. PubMed ID: 9048115 [No Abstract] [Full Text] [Related]
7. Dyslipidemia and coronary heart disease: management issues from Indian perspective. Gambhir DS; Gambhir JK; Sudha R Indian Heart J; 2000; 52(5):515-6, 617. PubMed ID: 11256772 [No Abstract] [Full Text] [Related]
9. The 2003 Canadian recommendations for dyslipidemia management: revisions are needed. Manuel DG; Tanuseputro P; Mustard CA; Schultz SE; Anderson GM; Ardal S; Alter DA; Laupacis A CMAJ; 2005 Apr; 172(8):1027-31. PubMed ID: 15824409 [No Abstract] [Full Text] [Related]
13. [Analysis of reasons for discontinuation of treatment for dyslipidemia in secondary prevention of coronary heart disease]. Tyszecka G Przegl Lek; 1999; 56(11):709-15. PubMed ID: 10800583 [TBL] [Abstract][Full Text] [Related]
14. [Milestone in the treatment of diabetic dyslipidemia: the DAIS Study]. Forster T Orv Hetil; 2001 Jul; 142(29):1588-9. PubMed ID: 11494751 [No Abstract] [Full Text] [Related]
15. [Treatment of coronary arteriosclerosis depending on the nature of lipid metabolism disorders]. Anisimov VE; Semavin IE Klin Med (Mosk); 1975 Jul; 53(7):66-9. PubMed ID: 1206996 [No Abstract] [Full Text] [Related]
17. [Treatment of hyperlipidemia with a new drug, tibric acid]. Carmena R; González R Florez J; Sanchis J Rev Clin Esp; 1976 Jul; 142(2):151-5. PubMed ID: 788065 [No Abstract] [Full Text] [Related]
18. Halofenate: an effective hypolipemia- and hypouricemia-inducing drug. Aronow WS; Vangrow JS; Nelson WH; Pagano J; Papageorge's NP; Khursheed M; Harding PR; Khemka M Curr Ther Res Clin Exp; 1973 Dec; 15(12):902-6. PubMed ID: 4203573 [No Abstract] [Full Text] [Related]
19. Dietary and pharmacologic therapy of the lipid risk factors. AMA Council on Scientific Affairs. Conn Med; 1985 May; 49(5):321-8. PubMed ID: 3891221 [No Abstract] [Full Text] [Related]
20. Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)? Sherrod JP; Krist A J Fam Pract; 2001 Nov; 50(11):928. PubMed ID: 11711006 [No Abstract] [Full Text] [Related] [Next] [New Search]